MedTrace Logo

Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis

NCT02549976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2018-07-31

No results posted yet for this study

Summary

The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.

Conditions

Interventions

PROCEDURE

Abdominal MRI

Abdominal MRI to realize within 4 months following inclusion

PROCEDURE

Upper endoscopy

Upper endoscopy to realize within 4 months following inclusion

PROCEDURE

Colonoscopy

Colonoscopy to realize within 4 months following inclusion

PROCEDURE

Pelvic MRI

Pelvic MRI to realize within 4 months following inclusion

Sponsors & Collaborators

  • Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

    lead OTHER

Principal Investigators

  • Benjamin Pariente, MD, PhD · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

  • Jacques Cosnes, MD · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02549976 on ClinicalTrials.gov